Circulating Level of Monocyte Chemoattractant Protein-1 and Risk of Coronary Artery Disease: A Case-Control and

Jing Li1, Yanqun Zhang1, Xue Guo1

  • 1Department of Health Care, Jinan People's Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, 271100, People's Republic of China.

Insights

Elevated monocyte chemoattractant protein-1 (MCP1) levels are linked to a higher risk of coronary artery disease (CAD). This finding suggests MCP1 may play a role in the development of this leading cause of death.

Area of Science:

  • Cardiovascular Research
  • Immunology
  • Genetics

Background:

  • Coronary artery disease (CAD) is a leading global cause of mortality.
  • Inflammation is recognized as a key factor in all stages of CAD and atherogenesis.
  • Monocyte chemoattractant protein-1 (MCP1) is a critical regulator of monocyte migration.

Purpose of the Study:

  • To investigate the association between CAD risk and genetic predisposition to circulating MCP1 levels.
  • To explore the role of MCP1 in the pathophysiology of coronary artery disease.

Main Methods:

  • A case-control study was conducted to assess the relationship between MCP1 levels and CAD risk.
  • A two-sample Mendelian randomization (MR) study was employed to examine the causal effect of genetically predicted MCP1 levels on CAD risk.
  • Sensitivity analyses, including MR Egger intercept tests, were performed to ensure the robustness of the findings and assess pleiotropy.

Main Results:

  • The case-control study revealed a significant association between higher circulating MCP1 levels and increased CAD risk (OR per quartile: 1.33).
  • Mendelian randomization analysis indicated that genetically predicted higher MCP1 levels were significantly associated with a higher risk of CAD (OR per 1-SD increase: 1.05).
  • Sensitivity analyses confirmed the main findings and found no evidence of directional pleiotropy.

Conclusions:

  • The study suggests a significant association between an increased predisposition to higher MCP1 levels and elevated risk of coronary artery disease.
  • Further research is warranted to fully elucidate the contribution of MCP1 to the pathogenesis of CAD.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
441
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
576
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
140
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
291
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
142